Fitbit reigns supreme as most used activity monitor for biomedical research

Activity trackers provide biomedical researchers with easy-to-obtain results with accuracy similar to research-grade monitors as a low-cost alternative. A study, published in the Federation of American Societies for Experimental Biology Journal, evaluated the most popular wearables to monitor physical activity.

Researchers evaluated information from Ovid Medline, PubMed Medline, clinicaltrials.gov and NIH RePorter that mentioned the Fitbit, Jawbone, Apple Watch, Garmin, Polar, Microsoftband, Misfit, Nike, Withings and Xiaomi. Results were quantified by condition/topic, intervention, enrollment status, study type and design, participant age, funding mechanism and primary outcome.

Overall, the Fitbit was the most used physician activity monitor with 89 percent of published work. Nearly 83 percent of clinical trials and 95 percent of NIH-funded research reported the use of the device. The Fitbit was primary used to measure physician activity and biomarkers of health including blood pressure and blood glucose levels.

The current state and potential growth of the consumer monitor technology is transforming biomedical research, and is enabling us to ask new and more granular questions about physical activity in health and disease,” concluded Stephen P. Wright, PhD, a medical researcher at Georgetown University, first author on the study, and colleagues.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.